GRI Bio, Inc. Share Price
NASDAQ: GRI | Micro CapGRI Bio, Inc. Stock Performance
GRI Bio, Inc. Share Price Today
As of 29 October 2026, GRI Bio, Inc.'s share price is $1.62. The stock opened at $1.62, compared to its previous close of $1.47. During today's trading session, GRI Bio, Inc.'s share price traded between $1.62 and $1.62, with an average price of $1.62. Over the past 52 weeks, the stock has recorded a high of $6.66 and a low of $0.18. In terms of performance, GRI Bio, Inc.'s share price has declined by 27.68% over the last six months and is down 3.57% on a year-on-year basis.
GRI Bio, Inc. Share Price Chart
GRI Bio, Inc. Quarterly Profit & Loss
All figures in USD
GRI Bio, Inc. Annual Profit & Loss
All figures in USD
About GRI Bio, Inc.
GRI Bio Inc is a clinical-stage biotech company focused on discovering, developing, and commercializing therapies targeting serious diseases associated with dysregulated immune responses that to inflammatory, fibrotic, and autoimmune disorders. GRI Bio's program, GRI-0621, is a small molecule RAR-beta and gamma dual agonist that inhibits the activity of human NKT I cells, returning the immune system to homeostasis. It is also an oral formulation of tazarotene, a synthetic RAR-beta and gamma selective agonist for the topical treatment of psoriasis and acne. The company's other product candidate GRI-0803 is a novel oral agonist of type 2 Natural Killer T (type 2 NKT) cells which can be a potential treatment for autoimmune disorders.
GRI Bio, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $1.96 | $1.62 | -24.65% |
Sep 2026 | $1.94 | $2.15 | +2.87% |
Aug 2026 | $1.45 | $2.09 | +46.15% |
Jul 2026 | $1.83 | $1.43 | -20.99% |
Jun 2026 | $2.03 | $1.81 | -12.14% |
May 2026 | $2.23 | $2.06 | -8.04% |
Apr 2026 | $2.39 | $2.24 | +0.90% |
Mar 2026 | $2.42 | $2.22 | -12.94% |
Feb 2026 | $3.13 | $2.55 | -21.66% |
Jan 2026 | $0.24 | $3.25 | +1,239.51% |
Dec 2025 | $1.97 | $0.24 | -87.85% |
Nov 2025 | $1.66 | $2.00 | +19.05% |